18F-FDG-PET/CT in predicting pathologic complete response after neoadjuvant chemotherapy: The early metabolic response is the answer

被引：0
|
作者：
Sanz-Viedma, Salome [1 ]
Sanchez-Munoz, Alfonso [2 ]
Scholz-Gutierrez, Victoria [3 ]
Manuel Jimenez-Hoyuela, Jose [1 ]
Alavi, Abass [4 ]
Alba, Emilio [2 ]
机构：
[1] Univ Hosp Virgen de la Victoria, Dept Nucl Med, Malaga, Spain
[2] Univ Hosp Virgen de la Victoria, Dept Med Oncol, Malaga, Spain
[3] Univ Hosp Virgen de la Victoria, Dept Surg, Malaga, Spain
[4] Hosp Univ Penn, Dept Nucl Med, Philadelphia, PA 19104 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷 / 16期
关键词：
BREAST-CANCER; TOMOGRAPHY;
D O I：
10.1016/j.ejca.2013.07.151
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3573 / 3574
页数：2
相关论文
共 50 条
  • [31] Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18F-FDG PET/CT and MRI
    Byun, Byung Hyun
    Kong, Chang-Bae
    Lim, Ilhan
    Kim, Byung Il
    Choi, Chang Woon
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [32] 18F-FDG-PET/CT
    Chierichetti, F.
    Pizzolato, G.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 56 (02): : 138 - 150
  • [33] Potential role of [18F]FDG-PET/CT in the evaluation of therapy response after neoadjuvant chemotherapy
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 159 - 159
  • [34] Correlation between baseline 18F-FDG PET/CT features and pathological complete response after neoadjuvant chemotherapy in early triple negative breast cancer
    Bouron, C.
    Mathie, C.
    Morel, O.
    Seegers, V
    Guillerminet, C.
    Lacoeuille, F.
    Patsouris, A.
    Testard, A.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2021, 45 (03): : 135 - 141
  • [35] The factors affecting pathologic complete response after neoadjuvant chemotherapy and the role of 18-FDG-PET/CT in patients with locally advanced breast cancer.
    Dane, Faysal
    Kaya, Serap
    Odabas, Hatice
    Aytekin, Aydin
    Yildirim, Nilgun
    Coban, Ezgi
    Sakalar, Teoman
    Aydin, Dincer
    Bilici, Mehmet
    Benekli, Mustafa
    Yumuk, Perran Fulden
    Gumus, Mahmut
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Assessment of tumor response by F-18 FDG PET/CT in osteosarcoma patients with neoadjuvant chemotherapy
    Han, E.
    Choi, E.
    Seo, Y.
    Choi, W.
    Yoo, I.
    Park, Y.
    Kang, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S476 - S476
  • [37] 18F-FDG PET/CT in predicting histopathologic response to neoadjuvant treatment in rectal cancer
    Crivellaro, Cinzia
    De Bernardi, Elisabetta
    Niespolo, Rita Marina
    De Ponti, Elena
    Guerra, Luca
    Borroni, Fulvio
    Terrevazzi, Sara
    Dolci, Carlotta
    Elisei, Federica
    Meregalli, Sofia
    Gardani, Gianstefano
    Landoni, Claudio
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [38] Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma
    Zamagni, Elena
    Nanni, Cristina
    Dozza, Luca
    Carlier, Thomas
    Bailly, Clement
    Tacchetti, Paola
    Versari, Annibale
    Chauvie, Stephane
    Gallamini, Andrea
    Gamberi, Barbara
    Caillot, Denis
    Patriarca, Francesca
    Macro, Margaret
    Boccadoro, Mario
    Garderet, Laurent
    Barbato, Simona
    Fanti, Stefano
    Perrot, Aurore
    Gay, Francesca
    Sonneveld, Peter
    Karlin, Lionel
    Cavo, Michele
    Bodet-Milin, Caroline
    Moreau, Philippe
    Kraeber-Bodere, Francoise
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (02) : 116 - +
  • [39] Prognostic value of metabolic complete response on 18F-FDG PET/CT in stage II or III breast cancer patients treated with neoadjuvant chemotherapy
    Chen, Suyun
    Ibrahim, Nuhad K.
    Wong, Stephen
    Wang, Hui
    Wong, Franklin
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [40] Primary tumor maxSUV by 18F-FDG PET/CT after neoadjuvant chemotherapy as predictive value for the pathologic response in locally advanced breast cancer
    Kang, S. H.
    Kwon, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S106 - S107
12345